Smith & Nephew has a solid, growing business which will grow with market growth as well as by acquisition. It has a decent dividend payment history. Don't expect amazing performance, but on a mid- to ...

The CORI Digital Tensioner produces a surgeon-defined, quantifiable force to distract the knee joint, apply consistent tension to the ligaments, and provide objective gap data for procedure planning ...

Smith+Nephew SNN recently introduced the FAST-FLIX FLEX Meniscal Repair System, which is the only device to provide a surgeon-guided, bendable needle and shaft allowing access to all zones of the ...

Smith+Nephew expects full-year reported growth of around 5.7%, reaffirming its prior guidance. It anticipates an expansion of ...

Business: Smith & Nephew is a British portfolio medical technology company that operates worldwide. The company develops, manufactures, markets and sells medical devices and services. Its segments ...

Innovative approaches to real world evidence collection present opportunities for medical device companies to improve patient outcomes. But success will depend on improving the way medtech companies ...

In 2023, ambulatory surgery centers, especially physician-owned ones, surged in arthroscopic procedures, pushing suppliers for competitive pricing, curbing inflation, and limiting market growth.” — Dr ...

Smith & Nephew Snats ( ($SNN) ) has issued an announcement. On November 6, 2025, Smith & Nephew plc announced a significant transaction involving ...

LONDON, April 24, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today introduced its new CORI™ Digital Tensioner - a purpose built device that lets ...